協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/11/29 | 2,095 | 2,104 | 2,076 | 2,093 | +7 | +0.3% | 1,008,900 |
2017/11/28 | 2,044 | 2,088 | 2,042 | 2,086 | +42 | +2.1% | 1,106,700 |
2017/11/27 | 2,057 | 2,073 | 2,036 | 2,044 | -24 | -1.2% | 1,088,500 |
2017/11/24 | 2,055 | 2,075 | 2,038 | 2,068 | -12 | -0.6% | 1,117,300 |
2017/11/22 | 2,125 | 2,138 | 2,076 | 2,080 | -30 | -1.4% | 1,287,800 |
2017/11/21 | 2,110 | 2,123 | 2,101 | 2,110 | -10 | -0.5% | 1,193,100 |
2017/11/20 | 2,149 | 2,156 | 2,114 | 2,120 | -44 | -2% | 1,039,600 |
2017/11/17 | 2,200 | 2,227 | 2,152 | 2,164 | -9 | -0.4% | 1,817,700 |
2017/11/16 | 2,074 | 2,178 | 2,074 | 2,173 | +109 | +5.3% | 1,650,800 |
2017/11/15 | 2,084 | 2,095 | 2,063 | 2,064 | -30 | -1.4% | 1,260,500 |
2017/11/14 | 2,089 | 2,119 | 2,079 | 2,094 | +5 | +0.2% | 1,001,800 |
2017/11/13 | 2,090 | 2,107 | 2,076 | 2,089 | -14 | -0.7% | 804,900 |
2017/11/10 | 2,096 | 2,114 | 2,070 | 2,103 | -13 | -0.6% | 1,486,200 |
2017/11/09 | 2,152 | 2,165 | 2,090 | 2,116 | -36 | -1.7% | 1,729,600 |
2017/11/08 | 2,167 | 2,171 | 2,131 | 2,152 | -42 | -1.9% | 1,416,100 |
2017/11/07 | 2,146 | 2,197 | 2,132 | 2,194 | +50 | +2.3% | 1,232,800 |
2017/11/06 | 2,172 | 2,181 | 2,129 | 2,144 | -11 | -0.5% | 845,200 |
2017/11/02 | 2,130 | 2,157 | 2,118 | 2,155 | +49 | +2.3% | 1,587,200 |
2017/11/01 | 2,107 | 2,112 | 2,082 | 2,106 | +18 | +0.9% | 1,328,100 |
2017/10/31 | 2,095 | 2,096 | 2,060 | 2,088 | -18 | -0.9% | 1,569,900 |
2017/10/30 | 2,108 | 2,112 | 2,079 | 2,106 | +13 | +0.6% | 2,404,700 |
2017/10/27 | 1,994 | 2,100 | 1,991 | 2,093 | +121 | +6.1% | 2,378,000 |
2017/10/26 | 1,984 | 1,997 | 1,960 | 1,972 | -24 | -1.2% | 1,229,500 |
2017/10/25 | 2,042 | 2,042 | 1,989 | 1,996 | -44 | -2.2% | 1,025,700 |
2017/10/24 | 2,030 | 2,044 | 2,023 | 2,040 | ±0 | ±0% | 655,200 |
2017/10/23 | 2,045 | 2,050 | 2,027 | 2,040 | +18 | +0.9% | 962,800 |
2017/10/20 | 2,020 | 2,039 | 2,009 | 2,022 | +3 | +0.1% | 954,000 |
2017/10/19 | 2,000 | 2,028 | 2,000 | 2,019 | +25 | +1.3% | 866,800 |
2017/10/18 | 2,000 | 2,001 | 1,985 | 1,994 | -4 | -0.2% | 1,019,100 |
2017/10/17 | 2,000 | 2,002 | 1,983 | 1,998 | +7 | +0.4% | 839,000 |
2017/10/16 | 1,973 | 1,996 | 1,967 | 1,991 | +10 | +0.5% | 791,600 |
2017/10/13 | 1,950 | 1,984 | 1,950 | 1,981 | +15 | +0.8% | 1,541,400 |
2017/10/12 | 1,984 | 1,984 | 1,965 | 1,966 | -12 | -0.6% | 710,800 |
2017/10/11 | 1,942 | 1,982 | 1,940 | 1,978 | +23 | +1.2% | 750,900 |
2017/10/10 | 1,939 | 1,956 | 1,928 | 1,955 | -5 | -0.3% | 914,000 |
2017/10/06 | 1,969 | 1,969 | 1,948 | 1,960 | ±0 | ±0% | 906,400 |
2017/10/05 | 1,960 | 1,961 | 1,946 | 1,960 | ±0 | ±0% | 738,900 |
2017/10/04 | 1,965 | 1,975 | 1,955 | 1,960 | -6 | -0.3% | 932,700 |
2017/10/03 | 1,918 | 1,968 | 1,908 | 1,966 | +52 | +2.7% | 1,312,200 |
2017/10/02 | 1,930 | 1,944 | 1,909 | 1,914 | ±0 | ±0% | 1,550,200 |
2017/09/29 | 1,882 | 1,914 | 1,875 | 1,914 | +26 | +1.4% | 1,493,400 |
2017/09/28 | 1,900 | 1,902 | 1,881 | 1,888 | -17 | -0.9% | 1,428,100 |
2017/09/27 | 1,937 | 1,948 | 1,892 | 1,905 | -11 | -0.6% | 1,230,300 |
2017/09/26 | 1,884 | 1,918 | 1,881 | 1,916 | +28 | +1.5% | 1,154,100 |
2017/09/25 | 1,894 | 1,897 | 1,874 | 1,888 | +11 | +0.6% | 1,291,800 |
2017/09/22 | 1,873 | 1,880 | 1,859 | 1,877 | +18 | +1% | 955,400 |
2017/09/21 | 1,852 | 1,877 | 1,848 | 1,859 | +16 | +0.9% | 1,012,900 |
2017/09/20 | 1,848 | 1,862 | 1,838 | 1,843 | -21 | -1.1% | 1,078,600 |
2017/09/19 | 1,847 | 1,867 | 1,842 | 1,864 | +26 | +1.4% | 1,325,100 |
2017/09/15 | 1,854 | 1,860 | 1,831 | 1,838 | -10 | -0.5% | 1,487,900 |
1701~
1750
件表示中 / 3581件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 257,000円 | +11.3% | -5.4% | 2.26% | 19.78倍 | 1.56倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 214,000円 | +5.7% | +3.9% | 2.68% | 10.65倍 | 1.41倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 502,900円 | +1.7% | -2.9% | 3.18% | 32.99倍 | 1.73倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 181,500円 | -3.5% | -50.2% | 4.41% | 14.70倍 | 1.09倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 274,400円 | +18.2% | +4.2% | 1.20% | 19.45倍 | 2.48倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム